English | Español

Regulatory
+ Regulatory
Amanda Rupp | Oct 1, 2016

NCI partners with Multiple Myeloma Research Foundation to build database
+ Regulatory
Amanda Rupp | Sep 30, 2016

FDA approves treatment for Duchenne muscular dystrophy
+ Regulatory
Amanda Rupp | Sep 29, 2016

Capitol Hill briefing emphasizes antibiotic resistance crisis
+ Regulatory
Amanda Rupp | Sep 29, 2016

Patients and doctors desire records-related improvements, research suggests
+ Regulatory
John Breslin | Sep 28, 2016

Taxpayers may shoulder financial burden for Obamacare risk corridor program, expert warns
+ Regulatory
Amanda Rupp | Sep 27, 2016

FDA launches contest to combat opioid-related deaths
+ Regulatory
John Breslin | Sep 27, 2016

Blanket drug price controls branded 'terrible' for innovation by former FDA official
+ Regulatory
Amanda Rupp | Sep 27, 2016

Mullin highlights new law against opioids in Oklahoma

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes